Literature DB >> 22574630

Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania.

Till Ittermann1, Robin Haring, Henri Wallaschofski, Sebastian E Baumeister, Matthias Nauck, Marcus Dörr, Markus M Lerch, Markus Lerch, Henriette E Meyer zu Schwabedissen, Dieter Rosskopf, Henry Völzke.   

Abstract

BACKGROUND: Associations between thyroid function and hepatic steatosis defined by enzymatic and sonographic criteria are largely unknown in the general population. Thus, the aim of the present study was to investigate the association between thyroid function tests and sonographic as well as enzymatic criteria of liver status in a large population-based study, the Study of Health in Germany (SHIP).
METHODS: Data from 3661 SHIP participants without a self-reported history of thyroid or liver disease were analyzed. Hepatic steatosis was defined as the presence of a hyperechogenic ultrasound pattern of the liver and increased serum alanine transferase concentrations. Serum thyroid-stimulating hormone (TSH), free triiodothyronine (FT3), and free thyroxine (FT4) concentrations were associated with hepatic steatosis using multinomial regression models adjusted for sex, age, physical activity, alcohol consumption, waist circumference, and food intake pattern.
RESULTS: We detected no consistent association of serum TSH and FT3 concentrations with hepatic steatosis. In contrast, serum FT4 concentrations were inversely associated with hepatic steatosis in men (odds ratio (OR)=0.04 [95% confidence interval (CI)=0.01; 0.17]) and women (OR=0.06 [95% CI=0.01; 0.42]).
CONCLUSIONS: Results from the present cross-sectional study suggest that low FT4 concentrations are associated with hepatic steatosis. Longitudinal and intervention studies are warranted to investigate whether hypothyroidism increases the risk of hepatic steatosis or vice versa.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22574630      PMCID: PMC3358110          DOI: 10.1089/thy.2011.0279

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  47 in total

1.  Risk in cardiovascular disease. Subclinical hypothyroidism is risk factor for coronary heart disease.

Authors:  P B Fowler
Journal:  BMJ       Date:  2000-07-15

Review 2.  The relationship between the thyroid gland and the liver.

Authors:  R Malik; H Hodgson
Journal:  QJM       Date:  2002-09

3.  The association between fatty liver disease and blood pressure in a population-based prospective longitudinal study.

Authors:  Katharina Lau; Roberto Lorbeer; Robin Haring; Carsten O Schmidt; Henri Wallaschofski; Matthias Nauck; Ulrich John; Sebastian E Baumeister; Henry Völzke
Journal:  J Hypertens       Date:  2010-09       Impact factor: 4.844

4.  Both hypothyroidism and hyperthyroidism enhance low density lipoprotein oxidation.

Authors:  V Sundaram; A N Hanna; L Koneru; H A Newman; J M Falko
Journal:  J Clin Endocrinol Metab       Date:  1997-10       Impact factor: 5.958

5.  Effects of thyroid hormone on GLUT4 glucose transporter gene expression and NIDDM in rats.

Authors:  C J Torrance; J E Devente; J P Jones; G L Dohm
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

6.  The effects of hypothyroidism on liver status of cirrhotic patients.

Authors:  R Oren; E Sikuler; F Wong; L M Blendis; Z Halpern
Journal:  J Clin Gastroenterol       Date:  2000-09       Impact factor: 3.062

Review 7.  Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.

Authors:  M D Danese; P W Ladenson; C L Meinert; N R Powe
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

Review 8.  Thyroid hormones in the pathogenesis and treatment of obesity.

Authors:  Marcin Krotkiewski
Journal:  Eur J Pharmacol       Date:  2002-04-12       Impact factor: 4.432

9.  Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design.

Authors:  U John; B Greiner; E Hensel; J Lüdemann; M Piek; S Sauer; C Adam; G Born; D Alte; E Greiser; U Haertel; H W Hense; J Haerting; S Willich; C Kessler
Journal:  Soz Praventivmed       Date:  2001

Review 10.  Thyroid disease and lipids.

Authors:  Leonidas H Duntas
Journal:  Thyroid       Date:  2002-04       Impact factor: 6.568

View more
  34 in total

1.  Thyroid function: low T₄ levels a risk factor for fatty liver?

Authors:  Fiona Mitchell
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

2.  High serum thyrotropin levels are associated with current but not with incident hypertension.

Authors:  Till Ittermann; Daniel Tiller; Christa Meisinger; Carsten Agger; Matthias Nauck; Rainer Rettig; Albert Hofman; Torben Jørgensen; Allan Linneberg; Jacqueline C M Witteman; Oscar H Franco; Karin H Greiser; Karl Werdan; Angela Döring; Alexander Kluttig; Bruno H C Stricker; Henry Völzke
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

3.  Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.

Authors:  Alessandro Mantovani; Giorgio Grani
Journal:  Dig Dis Sci       Date:  2018-04-19       Impact factor: 3.199

Review 4.  Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.

Authors:  Bassem Refaat; Adel Galal El-Shemi; Ahmed Ashshi; Esam Azhar
Journal:  Int J Clin Exp Med       Date:  2015-07-15

5.  Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Anawin Sanguankeo; Sikarin Upala
Journal:  Eur Thyroid J       Date:  2017-01-21

Review 6.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

Review 7.  Functions of autophagy in normal and diseased liver.

Authors:  Mark J Czaja; Wen-Xing Ding; Terrence M Donohue; Scott L Friedman; Jae-Sung Kim; Masaaki Komatsu; John J Lemasters; Antoinette Lemoine; Jiandie D Lin; Jing-hsiung James Ou; David H Perlmutter; Glenn Randall; Ratna B Ray; Allan Tsung; Xiao-Ming Yin
Journal:  Autophagy       Date:  2013-05-22       Impact factor: 16.016

8.  Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.

Authors:  Kil Woo Lee; Ki Bae Bang; Eun Jung Rhee; Heon Ju Kwon; Mi Yeon Lee; Yong Kyun Cho
Journal:  Clin Mol Hepatol       Date:  2015-12-24

Review 9.  Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.

Authors:  Ahad Eshraghian; Alireza Hamidian Jahromi
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

10.  Hepatic steatosis and thyroid function tests in overweight and obese children.

Authors:  L Pacifico; E Bonci; F Ferraro; G Andreoli; S Bascetta; C Chiesa
Journal:  Int J Endocrinol       Date:  2013-02-03       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.